Preliminary findings from pilot study validate use of wearable technologies to collect data and manage clinical trials more effectively and efficientlyLONDON, June 15, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation, today announced a collaboration with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials.Wearables have the potential to address several challenges related to clinical trials and improve execution by increasing patients’…

Source: RealWire

Leave a Reply